ACM
IBB icon

Alethea Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Alethea Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,385
Closed -$1.27M – 94
2017
Q3 		$1.27M Hold
11,385
– – 1.49% 24
2017
Q2 		$1.18M Buy
11,385
+1,593
+16% +$157K 1.34% 26
2017
Q1 		$957K Hold
9,792
– – 1.15% 28
2016
Q4 		$866K Buy
9,792
+60
+0.6% +$5.46K 1.09% 29
2016
Q3 		$939K Buy
9,732
+1,215
+14% +$116K 1.3% 27
2016
Q2 		$731K Sell
8,517
-6,924
-45% -$621K 1% 31
2016
Q1 		$1.34M Sell
15,441
-5,100
-25% -$456K 1.49% 27
2015
Q4 		$2.32M Sell
20,541
-360
-2% -$39.1K 2.68% 10
2015
Q3 		$2.11M Buy
+20,901
New +$2.51M 3.21% 8

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return